Silexion Therapeutics Corp (SLXN) concluded trading on Thursday at a closing price of $3.10, with 3.9 million shares of worth about $12.1 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -96.87% during that period and on December 05, 2024 the price saw a gain of about 10.32%. Currently the company’s common shares owned by public are about 0.43M shares, out of which, 0.24M shares are available for trading.
Stock saw a price change of 20.86% in past 5 days and over the past one month there was a price change of 30.67%. Year-to-date (YTD), SLXN shares are showing a performance of -96.83% which decreased to -96.56% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.86 but also hit the highest price of $122.02 during that period. The average intraday trading volume for Silexion Therapeutics Corp shares is 670.67K. The stock is currently trading 20.72% above its 20-day simple moving average (SMA20), while that difference is up 2.64% for SMA50 and it goes to -95.04% lower than SMA200.
Silexion Therapeutics Corp (NASDAQ: SLXN) currently have 0.43M outstanding shares and institutions hold larger chunk of about 30.17% of that.
The stock has a current market capitalization of $4.96M and its 3Y-monthly beta is at -0.06. It has posted earnings per share of -$1.26 in the same period. It has Quick Ratio of 1.75 while making debt-to-equity ratio of 1.32. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SLXN, volatility over the week remained 22.75% while standing at 19.19% over the month.
